MELANOMA, STAGE II
Clinical trials for MELANOMA, STAGE II explained in plain language.
Never miss a new study
Get alerted when new MELANOMA, STAGE II trials appear
Sign up with your email to follow new studies for MELANOMA, STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New copycat cancer drug enters human testing
Disease control OngoingThis study is testing a new, similar version of the cancer drug Keytruda (called FYB206) to see if it behaves the same way in the body. It involves patients with stage IIB/IIC or III melanoma who have had their cancer completely removed by surgery. The main goal is to check if th…
Matched conditions: MELANOMA, STAGE II
Phase: PHASE1 • Sponsor: Formycon AG • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Tracking the hidden toll: study maps immunotherapy side effects in cancer survivors
Knowledge-focused OngoingThis study observes melanoma survivors who have completed surgery and are receiving immunotherapy drugs to prevent cancer return. Researchers follow 126 patients for two years to track side effects, symptoms like fatigue and depression, and quality of life. The goal is to underst…
Matched conditions: MELANOMA, STAGE II
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC